Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish By: TalkMarkets January 11, 2023 at 05:30 AM EST 2023 can be the year of biotechs after two consecutive years of negative or barely positive returns. Read More >> Related Stocks: Biogen Idec Bristol-Myers Squibb Cassava Sciences, Inc. - Common Stock Eli Lilly Merck & Co Moderna, Inc. - Common Stock Pfizer Prothena Corporation plc - Ordinary Shares iShares 7-10 Year Treasury Bond ETF